4//SEC Filing
WILLSEY LANCE 4
Accession 0000939767-21-000023
CIK 0000939767other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 8:11 PM ET
Size
12.4 KB
Accession
0000939767-21-000023
Insider Transaction Report
Form 4
EXELIXIS, INC.EXEL
WILLSEY LANCE
Director
Transactions
- Exercise/Conversion
Option (right to buy)
2021-02-23−40,000→ 0 totalExercise: $3.38From: 2014-05-29Exp: 2021-05-28→ Common Stock (40,000 underlying) - Sale
Common Stock
2021-02-16$21.90/sh−50,000$1,095,000→ 424,415 total - Exercise/Conversion
Common Stock
2021-02-23$3.38/sh+40,000$135,200→ 464,415 total - Sale
Common Stock
2021-02-23$21.92/sh−39,200$859,264→ 425,215 total - Sale
Common Stock
2021-02-23$22.34/sh−800$17,872→ 424,415 total
Footnotes (4)
- [F1]Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.83 to $21.98. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.
- [F2]Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.31 to $22.30. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
- [F3]Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.31 to $22.37. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
- [F4]The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 29, 2014.
Documents
Issuer
EXELIXIS, INC.
CIK 0000939767
Entity typeother
Related Parties
1- filerCIK 0001202106
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 8:11 PM ET
- Size
- 12.4 KB